The EMT process leads to the loss of E‐cadherin in tumor cells and the high expression of N‐cadherin, which is also an important reason for first‐line chemotherapy resistance.SLC7A1 knockdown in tumor cells impaired cellular EMT progression (Figure 4F). The gene discussed is CDH2; the disease is neoplasm.